Carl Tilling

Publications and Insights

• Publication: The burden of LDL-cholesterol-driven atherosclerotic cardiovascular diseases
• Bulletin: Two perspectives on perspective
• Insight: Why do we expect obesity medicines to work differently?
• Publication: The case for adopting a broader perspective on value in Health Technology Assessment
• Publication: Patient preferences for treatment in relapsed/refractory acute leukemia
• Publication: Understanding the preferences of people with acute leukemia for different health outcomes
• Bulletin: Health economics and HTA: milestones and new directions
• Insight: Around the World in HTAs: Canada – Autonomous yet Collaborative
• Publication: Understanding societal preferences for priority by disease severity in England & Wales
• Bulletin: Who gets what? Health economics in action
• Publication: Incorporating the Patient Voice in Health Technology Assessment
• Publication: Individual, Health System, and Societal Impacts of Anti-seizure Medicine Use During Pregnancy
• Publication: The Burden of Hidradenitis Suppurativa on Patients, the NHS and Society
• Insight: Caring about Carers: Improving Consideration of the Burden of Informal Caring in HTA
• Publication: After the Transplant: Potential Benefits for the NHS and UK Kidney Transplant Patients
• Publication: A Case Study Analysis: Challenges in the NICE Evaluation of Multi-Indication Medicines for Rare and Ultra-Rare Diseases
• New: Opportunities to Increase Efficiency in Healthcare
• Publication: Opportunities to Increase Efficiency in Healthcare
• Publication: Ethical and Economic Issues in the Appraisal of Medicines for Ultra-Rare Conditions
• Publication: A Comparison of Alternative Variants of the Lead and Lag Time TTO